NCT02904213View on ClinicalTrials.gov

Evaluate Safety of ComBe Five (Liquid) in Healthy Vietnamese Children Aged From 8 - 10 Weeks as a 3-dose Series, Interval for Each Dose is 4 Weeks

NACompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

September 16, 2016

Primary Completion Date

December 19, 2016

Study Completion Date

June 24, 2017

Conditions
Safety, Pentavalent Vaccine
Interventions
BIOLOGICAL

ComBe Five (Liquid)

Trial Locations (1)

400000

Ha Nam Health Center, Hà Nam

Sponsors

Collaborators (1)

Biological E. Limited
All Listed Sponsors
collaborator

Biological E. Limited

UNKNOWN

lead

Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products

OTHER

NCT02904213 - Evaluate Safety of ComBe Five (Liquid) in Healthy Vietnamese Children Aged From 8 - 10 Weeks as a 3-dose Series, Interval for Each Dose is 4 Weeks | Biotech Hunter | Biotech Hunter